Potential value of circulating microRNA-126 and microRNA-210 as biomarkers for type 2 diabetes with coronary artery disease

References

• Hegazi R, El-Gamal M, Abdel-Hady, N, et al. Epidemiology of and risk factors for type 2 diabetes in Egypt. Ann Glob Health. 2015;81:814–820.10.1016/j.aogh.2015.12.011
   PubMed Web of Science ®Google Scholar
• Quan W, Jo EK, Lee MS. Role of pancreatic β-cell death and inflammation in diabetes. Diabetes Obes Metab. 2013;15(S3):141–151.10.1111/dom.2013.15.issue-s3
   PubMedGoogle Scholar
• Ryde'n L, Grant PJ, Anker SD, et al. ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J. 2013;34:3035–3087.
   PubMed Web of Science ®Google Scholar
• Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004;116(2):281–297.10.1016/S0092-8674(04)00045-5
   PubMed Web of Science ®Google Scholar
• Sun B, Liu X, Gao Y, et al. Downregulation of miR-124 predicts poor prognosis in pancreatic ductal adenocarcinoma patients. Br J Biomed Sci. 2016;73:152–157.10.1080/09674845.2016.1220706
   PubMed Web of Science ®Google Scholar
• Al-Kafaji G, Al-Mahroos G, Abdulla Al-Muhtaresh H, et al. Circulating endothelium-enriched microRNA-126 as a potential biomarker for coronary artery disease in type 2 diabetes mellitus patients. Biomarkers. 2017;22:268–278.10.1080/1354750X.2016.1204004
   PubMed Web of Science ®Google Scholar
• Wang S, Aurora AB, Johnson BA, et al. The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev Cell. 2008;15:261–271.10.1016/j.devcel.2008.07.002
   PubMed Web of Science ®Google Scholar
• Huang X, Le QT, Giaccia AJ. MiR-210 - micromanager of the hypoxia pathway. Trends Mol Med. 2010;16:230–237.10.1016/j.molmed.2010.03.004
   PubMed Web of Science ®Google Scholar
• Devlin C, Greco S, Martelli F, et al. MiR-210: More than a silent player in hypoxia. IUBMB Life. 2011;63:94–100.
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Classification and diagnosis of diabetes. Diabetes Care. 2016;39:S13–S22.
   PubMedGoogle Scholar
• Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499–502.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods 2001;25:402–408.10.1006/meth.2001.1262
   PubMed Web of Science ®Google Scholar
• Zampetaki A, Kiechl S, Drozdov I, et al. Plasma microRNA profiling reveals loss of endothelial MiR-126 and other microRNAs in type 2 diabetes. Circ Res. 2010;107:810–817.10.1161/CIRCRESAHA.110.226357
   PubMed Web of Science ®Google Scholar
• Rezk NA, Sabbah NA, Saad MS. Role of microRNA 126 in screening, diagnosis, and prognosis of diabetic patients in Egypt. IUBMB Life. 2016;68:452–458.10.1002/iub.v68.6
   PubMed Web of Science ®Google Scholar
• Zhang T, Li L, Shang Q, et al. Circulating miR-126 is a potential biomarker to predict the onset of type 2 diabetes mellitus in susceptible individuals. Biochem Biophys Res Commun. 2015;463:60–63.10.1016/j.bbrc.2015.05.017
   PubMed Web of Science ®Google Scholar
• Karolina DS, Tavintharan S., Armugam A, et al. Circulating miRNA profiles in patients with metabolic syndrome. J Clin Endocrinol Metab. 2012;97:E2271–E2276.10.1210/jc.2012-1996
   PubMed Web of Science ®Google Scholar
• Jansent F, Yang X., Proebsting S, et al. MicroRNA expression in circulating microvesicles predicts cardiovascular events in patients with coronary artery disease. J Am Heart Assoc. 2014;3:1–16.
   Web of Science ®Google Scholar
• Harris TA, Yamakuchi M, Ferlito M, et al. MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1. Proc Natl Acad Sci USA. 2008;105:1516–1521.10.1073/pnas.0707493105
   PubMed Web of Science ®Google Scholar
• Fish JE, Santoro MM, Morton SU, et al. miR-126 regulates angiogenic signaling and vascular integrity. Dev Cell. 2008;15:272–284.10.1016/j.devcel.2008.07.008
   PubMed Web of Science ®Google Scholar
• Fichtlscherer S, De Rosa S, Fox H, et al. Circulating microRNAs in patients with coronary artery disease. Cir Res. 2010;107:677–684.10.1161/CIRCRESAHA.109.215566
   PubMed Web of Science ®Google Scholar
• Nielsen LB, Wang C, Sørensen K, et al. Circulating levels of microRNA from children with newly diagnosed type 1 diabetes and healthy controls: evidence that miR-25 associates to residual beta-cell function and glycaemic control during disease progression. Exp Diabetes Res. 2012; Article ID 896362: 1–7.
   Google Scholar
• Nesca V, Guay C, Jacovetti C, et al. Identification of particular groups of microRNAs that positively or negatively impact on beta cell function in obese models of type 2 diabetes. Diabetologia. 2013;56:2203–2212.10.1007/s00125-013-2993-y
   PubMed Web of Science ®Google Scholar
• Girgis CM, Cheng K, Scott CH, et al. Novel links between HIFs, type 2 diabetes, and metabolic syndrome. Trends Endocrinol Metab. 2012;23:372–380.10.1016/j.tem.2012.05.003
   PubMed Web of Science ®Google Scholar
• Xi L, Chow C, Kong X. Role of tissue and systemic hypoxia in obesity and type 2 diabetes. J Diabetes Res. 2016;2016:1–3.10.1155/2016/1527852
   Google Scholar
• Dang K, Myers KA. The role of hypoxia-induced miR-210 in cancer progression. Int J Mol Sci. 2015;16:6353–6372.10.3390/ijms16036353
   PubMed Web of Science ®Google Scholar
• Li T, Cao H, Zhuang J, et al. Identification of miR-130a, miR-27b and miR-210 as serum biomarkers for atherosclerosis obliterans. Clin Chim Acta. 2011;412:66–70.10.1016/j.cca.2010.09.029
   PubMed Web of Science ®Google Scholar
• Chen KC, Liao YC, Wang JY, et al. Oxidized low-density lipoprotein is a common risk factor for cardiovascular diseases and gastroenterological cancers via epigenomical regulation of microRNA-210. Oncotarget. 2015;6:24105.10.18632/oncotarget.v6i27
   PubMed Web of Science ®Google Scholar
• Hu S, Huang M, Li Z, et al. MicroRNA-210 as a novel therapy for treatment of ischemic heart disease. Circulation. 2010; 122(11 S1): S124–S131.10.1161/CIRCULATIONAHA.109.928424
   PubMed Web of Science ®Google Scholar
• Fasanaro P, D’Alessandra Y, Di Stefano V, et al. MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand ephrin-A3. J Biol Chem. 2008;283:15878–15883.10.1074/jbc.M800731200
   PubMed Web of Science ®Google Scholar
• Song H, Zhang Z, Wang L. Small interference RNA against PTP-1B reduces hypoxia/reoxygenation induced apoptosis of rat cardiomyocytes. Apoptosis 2008;13(3):383–393.10.1007/s10495-008-0181-1
   PubMed Web of Science ®Google Scholar
• Maiuri MC, Tasdemir E, Criollo A, et al. Control of autophagy by oncogenes and tumor suppressor genes. Cell Death Differ. 2009;16:87–93.10.1038/cdd.2008.131
   PubMed Web of Science ®Google Scholar
• Ohnishi H, Oka T, Kusachi S, et al. Increased expression of connective tissue growth factor in the infarct zone of experimentally induced myocardial infarction in rats. J Mol Cell Cardiol. 1998;30:2411–2422.10.1006/jmcc.1998.0799
   PubMed Web of Science ®Google Scholar
• Lou YL, Guo F, Liu F, et al. miR-210 activates notch signaling pathway in angiogenesis induced by cerebral ischemia. Mol Cell Biochem. 2012;370:45–51.10.1007/s11010-012-1396-6
   PubMed Web of Science ®Google Scholar
• Yang W, Sun T, Cao J, et al. Downregulation of miR-210 expression inhibits proliferation, induces apoptosis and enhances radiosensitivity in hypoxic human hepatoma cells in vitro. Exp cell res. 2012;318:944–954.10.1016/j.yexcr.2012.02.010
   PubMed Web of Science ®Google Scholar
• Chio CC., Lin JW., Cheng HA., et al. MicroRNA-210 targets antiapoptotic Bcl-2 expression and mediates hypoxia-induced apoptosis of neuroblastoma cells. Arch toxicol. 2013;87:459–468.10.1007/s00204-012-0965-5
   PubMed Web of Science ®Google Scholar
• Li Y., Yang C., Zhang L., et al. MicroRNA-210 induces endothelial cell apoptosis by directly targeting PDK1 in the setting of atherosclerosis. Cell Mol Biol Lett. 2017;22(1):1369.10.1186/s11658-017-0033-5
   Google Scholar